Uricase Topology × Oxygen × Peroxide — Computational Design (comp-045)¶

Question¶

How can exact published and proposed UOX configurations be compared across substrate concentration, dissolved-oxygen context, KatG, VHb, and reaction-site catalase without assigning a published joint effect to either component or encoding a topology winner?

Current state¶

Design disposition: CANDIDATE_LAYOUT_GENERATED. Biological verdict: NOT_EVALUATED.

COMP-045 contains no biological measurements. It does not advance, eliminate, or rank intracellular, secreted, displayed, or koji-secreted UOX. It generates a blocked experimental template whose exact constructs, controls, stocks, oxygen targets, sampling plan, and assay qualifications must be fixed before wet-lab execution.

Evidence boundary¶

Gao/PULSE provides In Vitro activity precedents at 250 µM urate for three exact EcN configurations: intracellular smUOX+YgfU, LamB-smUOX, and InaK-N-smUOX. The paper also compared each topology with the same joint KatG+VHb module under its low-oxygen method. It did not test KatG-only or VHb-only UOX configurations.

Zhao provides a related In Vitro intracellular PucL-mutant/PucM+YgfU+KatG+VHb precedent, not the exact PULSE smUOX construct. Gencer provides a related intracellular PucLM+YgfU precedent without KatG or VHb. Neither related configuration is relabeled as exact PULSE evidence.

For LamB and InaK-N UOX, the joint construct is direct whole-configuration evidence, but intracellular KatG is not located at the extracellular UOX reaction site. The reported comparison therefore does not establish extracellular peroxide closure. InaK-N fusion and whole-cell activity were reported, but a dedicated surface-accessibility localization assay was not.

No primary source in the bounded COMP-045 search establishes secreted active UOX in A. oryzae. Both koji rows are proposed configuration classes. Host-catalase localization and activity remain unresolved for the eventual strain and culture condition; no host-catalase state establishes peroxide control at a secreted-UOX reaction site.

Substrate regimes¶

0 µM: matched no-urate control.
0.59 µM: rounded direct human observational measurement from terminal-ileal fluid in a 34-patient clinically indicated balloon-enteroscopy cohort; not a Clinical Trial, not a jejunal or healthy-population baseline, and not tested in the cited UOX configurations.
50 µM: sensitivity scenario only.
250 µM: lowest reported PULSE topology-assay concentration.

PULSE used filled, sealed tubes without a reported dissolved-oxygen target. Zhao used approximately 15% of normal dissolved oxygen. A new microoxic label is not an exact match to both sources; each wet-lab oxygen target must be predeclared and measured.

Candidate design¶

Schema 3 defines:

18 candidate configuration classes and 20 block assignments;
16 preregistered same-block contrasts, including both directions of the catalase × VHb simple comparisons for LamB and InaK-N;
active UOX plus an otherwise support-module-matched inactive-UOX control at every concentration;
three provisional biological-run slots × two planned oxygen contexts × two blocks; actual dissolved-oxygen targets must later be predeclared and measured;
12 full 96-well plates with deterministic SHA-256 allocation;
chemical, dissolved-oxygen, viability, and UOX/KatG/VHb/reaction-site-catalase qualification readouts.

Two LamB comparator configurations repeat across blocks so the KatG/VHb and proposed reaction-site-catalase contrasts each retain a within-block comparator. The three-run value fills a deterministic plate template; it is not a power or precision claim. The mixed three-topology PULSE-KV composition is a proposed cross-plate anchor, not a published in-vitro positive control.

Research conjecture — What drives the joint-module benefit outside the cell?

Grounded premises: PULSE compared exact LamB and InaK-N UOX configurations with and without joint KatG+VHb under its low-oxygen method (In Vitro; source: Gao 2025, PMID 41038159). KatG remained intracellular while UOX activity was associated with supernatant or whole cells; extracellular reaction-site peroxide closure was not measured.

Novel leap: The observed joint-module difference may reflect VHb-mediated oxygen/cell-fitness support, intracellular ROS handling, or both rather than extracellular peroxide closure. No direct evidence separates those explanations.

Why it matters: The answer determines whether to invest in intracellular support, reaction-site catalase, or both.

Discriminating observation: Compare no module, KatG only, VHb only, joint KatG+VHb, and reaction-site catalase with matched product, dissolved oxygen, H₂O₂, viability, localization, and epithelial-exposure readouts.

Wet-lab readiness¶

BLOCKED_PENDING_EXACT_CONTROL_SAMPLING_AND_ANALYSIS_QUALIFICATION

Before execution, bind and review:

exact active/inactive UOX identities, retained activity, and matched expression/localization criteria;
exact KatG, VHb, and reaction-site-catalase constructs, retained function, localization, and co-expression compatibility;
chassis and mixed-anchor stocks plus cell normalization;
dissolved-oxygen targets;
sampling times, volume, aliquoting, and destructive-assay compatibility;
sensitivity and quantification limits at 0.59 µM;
exact UOX, KatG, VHb, reaction-site-catalase, topology, and oxygen qualification results;
a preregistered estimand, effect metric, biological threshold, power or precision rationale and run count, model, multiplicity treatment, exclusion/missing-data/assay-failure rules, and sensitivity rules.

The template must be regenerated under a new exact lifecycle if the qualified subset, contrasts, concentrations, blocks, or controls change.

What would advance or redirect the track¶

A topology can advance only from measured within-host, exact-configuration contrasts with qualified controls. Cross-host observations remain configuration-specific. A negative result applies to the tested construct × concentration × oxygen × control regime; it does not kill gut-lumen UOX, another topology, another chassis, or the project.